27. Stevanovic P. Midazolam:clinical practice guidelines. Med Pregl 59: 89-94, 2006.
28. Stoelting R.K. Opioid Agonist And Antagonist. In: Pharmacology & Physiolgy. Anesthetic Practice, 4th edition, pp.77-111: Lippincot-Raven, Philadelphia, USA 1999.
29. Derbyshire DR., Chimelewski A, Fell D, Vater M, Achola K, Smith G. Plazma catecolamine responses to tracheal intubation. British Journal of Anesthesia 55, 855-859. 1993.
30. Erdine S. Ağrı. 3. Basım, s.581-605, Nobel Tıp Kitabevi, İstanbul, 2007. 31. Sanders RD, Weimann J, Maze M. Biologic effects of nitrous oxide: a mechanistic and toxicologic review. Anesthesiology 109: 707-722, 2008. 32. Choi BO, Kim NK, Kim SH, Kang MS, Lee S, Ahn JY, Kim OJ, Kim S, Oh D.Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thromb Res 111: 39-44, 2003. 33. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den HM, Kluijtmans LA, van den Heuvel LP. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113, 1995. 34. Li Z, Sun L, Zhang H, Liao Y, Wang D, Zhao B, Zhu Z, Zhao J, Ma A, Han Y, Wang Y, Shi Y, Ye J, Hui R. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter CaseControl Study in China. Stroke 34: 2085-2090, 2003. 35. Lopaciuk S, Bykowska K, Kwiecinski H, Mickielewicz A, Czlonkowska A, Mendel T, Kuczynska-Zardzewialy A, Szelagowska D, Windyga J, Schroder W, Herrmann FH, Jedrzejowska H. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost 7: 346-350, 2001. 36. Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke 28: 1739-1743, 1997.
42 – 42 –



55. SAYFAYA BENZER SAYFALAR

Çocukluk çağı iskemik inmeli hastalarda protrombin g20210a mutasyonu, metilentetrahidrofolat redüktaz c677t mutasyonu ve hiperhomosisteineminin değerlendirilmesi - Sayfa 69
98. Endler G, Kyrle PA, Eichinger S, Exner M, Mannhalter C. Multiplexed mutagenically separated PCR: simultaneous single-tube detection of the factor V R506Q (G1691A), the prothrombin G20210A, and the methylenetetrahydrofolate reductase A223V (C677T) variants. Clin Chem 2001;47(2):333-5. 99. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor fo...
Hipertansif kişilerin ailesinde genetik yatkınlık ve lipid profili - Sayfa 113
97 the C677T mutation in the methylenetetrahydrofolate reductase gene. J Nutr, 2000;130: 2238-2242. 144. Goyette P, Pai A, Milos R, et al. Gene structure of human mouse methylenetetrahydrofolate reductase (MTHFR). Mammalian Genome, 1998; 9:652-656. 145. Kim OJ, Hong SP, Ahn JY, et al. Influence of combined methionine synthase (MTR 2756A > G) and methylenetetrahydrofolate reductase (MTHFR 677C > T...
Non alkolik steatohepatit ile MTHFR a1298c ve c677t gen polimorifizmleri arasindaki ilişki - Sayfa 44
90. 91. 92. 93. 94. 95. 96. 97. 98. 99. 100. 101. 102. 103. 104. Wu Y, T.M., Sumıno K, Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke: sex difference in Japanese. Kobe J Med Sci, 2001. 47: p. 255-62. Rosenblatt D S, Methylenetetrahydrofolate reductase. Clin Invest Med, 2001. 24: p. 56-59. Homberger G, L.M., Winter C, et al., Genomic structure and transcript varia...

55. SAYFADAKI ANAHTAR KELIMELER

homocysteine
gene
risk
with
disease
mthfr


55. SAYFA ICERIGI

27. Stevanovic P. Midazolam:clinical practice guidelines. Med Pregl 59: 89-94, 2006.
28. Stoelting R.K. Opioid Agonist And Antagonist. In: Pharmacology & Physiolgy. Anesthetic Practice, 4th edition, pp.77-111: Lippincot-Raven, Philadelphia, USA 1999.
29. Derbyshire DR., Chimelewski A, Fell D, Vater M, Achola K, Smith G. Plazma catecolamine responses to tracheal intubation. British Journal of Anesthesia 55, 855-859. 1993.
30. Erdine S. Ağrı. 3. Basım, s.581-605, Nobel Tıp Kitabevi, İstanbul, 2007. 31. Sanders RD, Weimann J, Maze M. Biologic effects of nitrous oxide: a mechanistic and toxicologic review. Anesthesiology 109: 707-722, 2008. 32. Choi BO, Kim NK, Kim SH, Kang MS, Lee S, Ahn JY, Kim OJ, Kim S, Oh D.Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thromb Res 111: 39-44, 2003. 33. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den HM, Kluijtmans LA, van den Heuvel LP. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113, 1995. 34. Li Z, Sun L, Zhang H, Liao Y, Wang D, Zhao B, Zhu Z, Zhao J, Ma A, Han Y, Wang Y, Shi Y, Ye J, Hui R. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter CaseControl Study in China. Stroke 34: 2085-2090, 2003. 35. Lopaciuk S, Bykowska K, Kwiecinski H, Mickielewicz A, Czlonkowska A, Mendel T, Kuczynska-Zardzewialy A, Szelagowska D, Windyga J, Schroder W, Herrmann FH, Jedrzejowska H. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost 7: 346-350, 2001. 36. Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke 28: 1739-1743, 1997.
42 – 42 –

İlgili Kaynaklar







single.php